Nu­clear scare to fu­el an­ti-ra­di­a­tion drug sales? PTx buys ex-Sanofi drug just in case

Part­ner Ther­a­peu­tics (PTx), a Boston start­up formed last week by a pair of Mer­ri­mack and Ser­agon ex­ec­u­tives, has made its first move: it’s ac­quired …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA